Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

Astria Therapeutics Stock News

ATXSNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$12.88

-0.045-0.35%

Last update: Dec 16, 11:07 AM

News

Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Latest Astria Therapeutics Stock News | NASDAQ:ATXS | Benzinga

Get the latest news on Astria Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Astria Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, November 12, 2025

Cantor Fitzgerald Downgrades Astria Therapeut...
Benzinga Newsdesk
Astria Therapeutics Q3 EPS $(0.55) Misses $(0...
Benzinga Newsdesk

Thursday, November 06, 2025

Astria Therapeutics ALPHA-STAR Phase 1b/2 Stu...
Benzinga Newsdesk

Friday, October 31, 2025

Astria Therapeutics To Present Final Results ...
Benzinga Newsdesk

Thursday, October 16, 2025

This Verisk Analytics Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday
Avi Kapoor
HC Wainwright & Co. Downgrades Astria Therape...
Benzinga Newsdesk

Wednesday, October 15, 2025

Wedbush Downgrades Astria Therapeutics to Neu...
Benzinga Newsdesk
JMP Securities Downgrades Astria Therapeutics...
Benzinga Newsdesk

Tuesday, October 14, 2025

Jefferies Downgrades Astria Therapeutics to H...
Benzinga Newsdesk
Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate'
Vandana Singh
Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Trading Halt: Halt status updated at 7:15:00 ...
Benzinga Newsdesk
BioCryst to Acquire Astria Therapeutics for M...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk

Wednesday, October 08, 2025

Astria Therapeutics Initiates Phase 3 ORBIT-E...
Benzinga Newsdesk

Friday, October 03, 2025

Astria Therapeutics To Present New Data On It...
Benzinga Newsdesk

Thursday, October 02, 2025

Astria Therapeutics Begins Opening Clinical T...
Benzinga Newsdesk

Wednesday, September 17, 2025

HC Wainwright & Co. Maintains Buy on Astria T...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on As...
Benzinga Newsdesk
ATXS stock has given up its prior loss. Astri...
Benzinga Newsdesk
Astria Therapeutics shares are trading lower....
Benzinga Newsdesk
Astria Therapeutics Releases Initial Phase 1a...
Benzinga Newsdesk

Wednesday, September 03, 2025

Astria Therapeutics To Present Phase 1a Trial...
Benzinga Newsdesk

Wednesday, August 13, 2025

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk

Tuesday, August 12, 2025

Astria Therapeutics Q2 EPS $(0.57) Beats $(0....
Benzinga Newsdesk

Wednesday, August 06, 2025

Astria Therapeutics Licenses D&C Rights In Ja...
Benzinga Newsdesk

Friday, June 13, 2025

HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Astria Therapeutics Reports Initial Results F...
Benzinga Newsdesk

Friday, May 23, 2025

Astria Therapeutics To Present Safety And Eff...
Benzinga Newsdesk

Wednesday, May 14, 2025

Cantor Fitzgerald Reiterates Overweight on As...
Benzinga Newsdesk

Tuesday, May 13, 2025

Astria Therapeutics Q1 EPS $(0.58) Misses $(0...
Benzinga Newsdesk

Thursday, May 01, 2025

Astria Therapeutics Publishes Navenibart Phas...
Benzinga Newsdesk

Tuesday, April 29, 2025

Cantor Fitzgerald Initiates Coverage On Astri...
Benzinga Newsdesk

Wednesday, March 12, 2025

Wedbush Maintains Outperform on Astria Therap...
Benzinga Newsdesk

Tuesday, March 11, 2025

HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Astria Therapeutics Q4 EPS $(0.44) Beats $(0....
Benzinga Newsdesk

Monday, March 03, 2025

Citizens Capital Markets Reiterates Market Ou...
Benzinga Newsdesk

Thursday, February 27, 2025

HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Astria Therapeutics Initiates ALPHA-ORBIT Pha...
Benzinga Newsdesk

Friday, January 31, 2025

JMP Securities Initiates Coverage On Astria T...
Benzinga Newsdesk

Thursday, January 23, 2025

HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Astria Therapeutics Initiates Phase 1a Trial ...
Benzinga Newsdesk

Monday, January 13, 2025

HC Wainwright & Co. Reiterates Buy on Astria ...
Benzinga Newsdesk
Astria Therapeutics Announces ALPHA-ORBIT Pha...
Benzinga Newsdesk

Tuesday, December 24, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

KalVista Pharmaceuticals Inc

CytomX Therapeutics Inc

Gyre Therapeutics Inc

Replimune Group Inc

Day One Biopharmaceuticals Inc

MapLight Therapeutics Inc

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved